Tower Research Capital LLC (Trc) Rhythm Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,058 shares of RYTM stock, worth $62,612. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,058
Previous 4,539
76.69%
Holding current value
$62,612
Previous $253,000
77.87%
% of portfolio
0.0%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding RYTM
# of Institutions
245Shares Held
62.9MCall Options Held
403KPut Options Held
62.8K-
Black Rock Inc. New York, NY6.74MShares$399 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$360 Million6.69% of portfolio
-
Primecap Management CO Pasadena, CA5.79MShares$342 Million0.26% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$332 Million3.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$204 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.3B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...